Abstract

The Public Health Agency of Sweden has conducted an investigation into whether the national vaccination programme for children against human papilloma virus (HPV), which today is limited to girls, should be extended to also include boys.

This report describes the health economic evaluation that together with 12 other factors make up the 13 factors that the Public Health Agency of Sweden accounts for when proposing changes in the national vaccination programme to the government. These 13 factors together constitute the basis for making a decision on whether to extend the HPV-vaccination programme to boys. The main target group for this publication is the government of Sweden (the Ministry of Health and Social Affairs). It could also be of interest for health professionals, foreign ministries of health, and public health institutions contemplating universal vaccination programmes against HPV.

The report was composed by Ellen Wolff, health economist at the unit for Epidemiology and Health Economics at the Public Health Agency of Sweden, in collaboration with a working group consisting of both analysts from the Public Health Agency of Sweden and external experts (see Appendix 1).

  • Background paper
  • Europe
  • Sweden
  • Human papillomavirus (HPV)